Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05178979
Other study ID # K01MH121663-01A1
Secondary ID 1K01MH121663-01A
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date December 31, 2021
Est. completion date December 31, 2023

Study information

Verified date January 2023
Source The University of Texas at San Antonio
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Gender norms embedded in the health-system and broader community shape patient-provider relationships in ways that may undermine the provision of antiretroviral treatment (ART) counseling for men and women in Uganda. This study seeks to develop and evaluate the acceptability, feasibility, and preliminary efficacy of an innovative gender transformative implementation strategy to improve HIV provider capacity for equitable HIV care and ART adherence counseling.


Description:

Antiretroviral treatment (ART) is the single most effective clinical intervention in the fight against HIV. However, in Uganda only 56% of people living with HIV were virally suppressed in 2017 with significant disparities between men and women, suggesting problems with implementation. While gender norms are a known driver of HIV disparities in sub-Saharan Africa, and patient-provider relationships are a key factor in HIV care engagement, little research has focused on the role that gender norms have in shaping the equitable provision of treatment and quality of ART counseling. The overall research objective is to develop and pilot test an implementation strategy to increase providers' capacity to provide equitable and gender-tailored treatment and counseling to HIV-infected men and women. Delivered to HIV providers, this group training integrates a gender transformative approach with adapted evidence-based strategies to reduce biases and increase gender equitable attitudes. The pilot trial will assess the implementation strategy's effectiveness by comparing changes in provider (competence for gender sensitive care) and in patient outcomes (clinic attendance, ART adherence, viral load) between the training intervention and usual care through 12-months. The implementation strategy will be assessed through a quasi-experimental pre/post design. Clinics will be randomly assigned to either the intervention or control condition. Providers in the intervention condition will receive a series of group training sessions. All participants in the provider cohort will complete interviewer administered questionnaires at baseline, 6-, and 12- month follow-up. In addition to the assessment of the cohort of HIV providers, the study will obtain additional data on the impact of the provider training on patient outcomes. Patient participants will complete an interviewer administered questionnaire at baseline, 6-, and 12- month follow-up, and will provide permission for the study team to review and extract relevant data from their clinic records related to engagement in HIV care. The total N and primary outcomes reflected in the clinicaltrials.gov database reflects the patient cohort (N=240, 120 per treatment arm). Secondary outcomes are obtained from the provider cohort (n=20-35 providers per clinic).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 383
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Provider Cohort: Inclusion Criteria: - HIV care provider at the selected clinics, including HIV medical and clinical officers, nurses, midwives, linkage facilitators, counselors. - 18 years of age or older - Fluent in English or Luganda Patient Cohort: Inclusion Criteria: - HIV-infected - Enrolled in care at the clinic of recruitment - pre-ART (newly diagnosed) or newly initiated on ART (within 3 months-1 year) or struggling with treatment adherence, defined in two ways: (1) most recent viral load results unsuppressed as assessed through clinic records; (2) or self-reported non-adherence as by the Adult AIDS Clinical Trials Group (AACTG) scale 4-day adherence recall questions. This scale has demonstrated good construct validity in Uganda and strong correlations with viral load; - 18 years of age or an emancipated minor - Fluent in Luganda or English

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Training
This training program integrates evidence-based strategies to reduce provider bias, adapted to address gender bias in the context of HIV care in Uganda. The content aims to increase providers' knowledge, motivation, skills, and empathy to equitably deliver Ugandan Ministry of Health ART program guidelines to male and female patients (e.g., increasing awareness of HIV gender disparities, increasing empathy/skills to counsel men and women's gendered barriers to care, promoting shared decision-making). The intervention is delivered in a series of group training sessions with HIV providers.

Locations

Country Name City State
Uganda Luwero Health HCIV Luwero
Uganda Namayumba Health HCIV Namayumba

Sponsors (3)

Lead Sponsor Collaborator
The University of Texas at San Antonio Makerere University, National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

Uganda, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in proportion of missed antiretroviral (ARV) doses from baseline among patients AACTG Adherence Instruments, self-reported questionnaire on medication adherence from the Adult AIDS Clinical Trials Group (AACTG); operationalized as a proportion of total missed doses (missed doses/total doses) (continuous measure, range =0.0-1.0) 6-months
Primary Change in proportion of missed ARV doses from baseline among patients AACTG Adherence Instruments, self-reported questionnaire on medication adherence from the Adult AIDS Clinical Trials Group (AACTG); operationalized as a proportion of total missed doses (missed doses/total doses) (continuous measure, range =0.0-1.0) 12-months
Primary Change in antiretroviral treatment (ART) adherence (90% of doses taken as prescribed) from baseline among patients AACTG Adherence Instruments, self-reported questionnaire on medication adherence from the Adult AIDS Clinical Trials Group (AACTG); operationalized as having taken 90% of doses as prescribed in the reporting period (dichotomous measure: 0 not adherent; 1 adherent) 6-months
Primary Change in ART adherence (90% of doses taken as prescribed) from baseline among patients AACTG Adherence Instruments, self-reported questionnaire on medication adherence from the Adult AIDS Clinical Trials Group (AACTG); operationalized as having taken 90% of doses as prescribed in the reporting period (dichotomous measure: 0 not adherent; 1 adherent) 12-months
Primary Change in number of missed visits accrued (count measure) from baseline among patients Number of missed visits accrued based on scheduled visits determined by Ministry of Health clinical guidelines, collected through clinic records 6-months
Primary Change in number of missed visits accrued (count measure) from baseline among patients Number of missed visits accrued based on scheduled visits determined by Ministry of Health clinical guidelines, collected through clinic records 12-months
Primary Change in clinic visit adherence from baseline among patients Proportion of kept visits/scheduled visits (kept + missed visits) (continuous measure, range =0.0-1.0) 6-months
Primary Change in clinic visit adherence from baseline among patients Proportion of kept visits/scheduled visits (kept + missed visits) (continuous measure, range =0.0-1.0) 12-months
Secondary Change in viral load from baseline to 12 months follow-up among patients Viral load 12-months
Secondary Change in overall satisfaction with HIV clinical care from baseline among patients Adapted from Consumer Satisfaction Survey and User's Manual, self-reported questionnaire, using version previously adapted for HIV populations - Total possible score using mean scoring: 0-4 (high score = better outcome) 6-months
Secondary Change in overall satisfaction with HIV clinical care from baseline among patients Adapted from Consumer Satisfaction Survey and User's Manual, self-reported questionnaire, using version previously adapted for HIV populations - Total possible score using mean scoring: 0-4 (high score = better outcome) 12-months
Secondary Change in gender awareness from baseline among providers Adapted from the Nijmegen Gender Awareness in Medicine Scale (N-GAMS); collected from provider cohort; 9 items, total possible score using mean scoring: 1-5 (high score = better outcome) 6-months
Secondary Change in gender awareness from baseline among providers Adapted from the Nijmegen Gender Awareness in Medicine Scale (N-GAMS); collected from provider cohort; 9 items, total possible score using mean scoring: 1-5 (high score = better outcome) 12-months
Secondary Change in awareness of gender disparities in HIV care from baseline among providers Awareness of societal gender inequities in the provider cohort, adapted to be specific to gender from the Self-Rated Cultural Competence Instrument for Primary Care Providers Total possible score using mean scoring: 1-5 (high score = better outcome) 6-months
Secondary Change in awareness of gender inequities from baseline among providers Awareness of societal gender inequities in the provider cohort, adapted to be specific to gender from the Self-Rated Cultural Competence Instrument for Primary Care Providers
5-items; total possible score using mean scoring: 1-5 (high score = better outcome)
12-months
Secondary Change in perceived importance of gender sensitive counseling from baseline among providers Perceived importance of providing gender sensitive counseling in the provider cohort, adapted to be specific to gender from the Self-Rated Cultural Competence Instrument for Primary Care Providers Total possible score using mean scoring: 1-5 (high score = better outcome) 6-months
Secondary Change in perceived importance of gender sensitive counseling from baseline among providers Perceived importance of providing gender sensitive counseling in the provider cohort, adapted to be specific to gender from the Self-Rated Cultural Competence Instrument for Primary Care Providers Total possible score using mean scoring: 1-5 (high score = better outcome) 12-months
Secondary Change in gender sensitive counseling skills from baseline among providers Self-reported change in gender sensitive counseling skills and behaviors in the provider cohort, adapted to be specific to gender from the Self-Rated Cultural Competence Instrument for Primary Care Providers
Total possible score using mean scoring: 1-5 (high score = better outcome)
6-months
Secondary Change in gender sensitive counseling skills from baseline among providers Self-reported change in gender sensitive counseling skills and behaviors in the provider cohort, adapted to be specific to gender from the Self-Rated Cultural Competence Instrument for Primary Care Providers
Total possible score using mean scoring: 1-5 (high score = better outcome)
12-months
Secondary Change in self-efficacy for gender specific provider communication from baseline among providers Self-reported change in self-efficacy to provide gender sensitive patient-centered communication in the provider cohort, adapted to be specific to gender from the Self Efficacy Questionnaire (SE-12)
Total possible score using mean scoring: 1-5 (high score = better outcome)
6-months
Secondary Change in self-efficacy for gender specific provider communication from baseline among providers Self-reported change in self-efficacy to provide gender sensitive patient-centered communication in the provider cohort, adapted to be specific to gender from the Self Efficacy Questionnaire (SE-12)
Total possible score using mean scoring: 1-5 (high score = better outcome)
12-months
Secondary Change in Gender Equitable Norms from baseline among providers Self-reported attitudes towards gender equity measured with the Gender Equitable Men scale
Total possible score using mean scoring: 1-3 (high score = worse outcome)
6-months
Secondary Change in Gender Equitable Norms from baseline among providers Self-reported attitudes towards gender equity measured with the Gender Equitable Men scale
Total possible score using mean scoring: 1-3 (high score = worse outcome)
12-months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Adherence to Anti- Retroviral Therapy (ART) Among People Living With Human Immunodeficiency Virus (HIV) Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2